9 Chapter 19 Chapter 20 Chapter 21 Chapter 22 Chapter 23 Chapter 24 Chapter 25 Chapter 26 PART IV: EVALUATING THERAPEUTIC EFFECTS ON BIOMARKERS IN IBD Inulin-grown Faecalibacterium prausnitzii cross-feeds fructose to the human intestinal epithelium Gut Microbes 2021;13(1):1993582. Vitamin C supplementation in healthy individuals leads to shifts of bacterial populations in the gut: a pilot study Antioxidants 2021;10(8):1278. The effect of riboflavin supplementation on the systemic redox status in healthy volunteers: a post-hoc analysis of the RIBOGUT trial Free Radical Biology and Medicine 2022;190:169-178. Riboflavin supplementation in patients with Crohn’s disease (the RISE-UP study) Journal of Crohn’s and Colitis 2020;14(5):595-607. The effect of induction therapy with infliximab or vedolizumab on hepcidin and iron status in patients with inflammatory bowel disease Submitted Serological biomarkers of intestinal collagen turnover identify early response to infliximab therapy in patients with Crohn’s disease Frontiers in Medicine 2022;9:933872. Serological biomarkers of extracellular matrix turnover and neutrophil activity are associated with long-term use of vedolizumab in patients with Crohn’s disease International Journal of Molecular Sciences 2022;23(15):8137. Mucosal eosinophil abundance in non-inflamed colonic tissue is associated with response to vedolizumab induction therapy in inflammatory bowel disease Journal of Clinical Medicine 2022;11(14):4141. 631 633 667 687 719 757 795 827 855
RkJQdWJsaXNoZXIy MjY0ODMw